BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16406129)

  • 1. Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine.
    Müller CP; Huston JP
    Trends Pharmacol Sci; 2006 Feb; 27(2):105-12. PubMed ID: 16406129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
    Bubar MJ; Cunningham KA
    Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interplay between brain 5-hydroxytryptamine levels and cocaine addiction.
    Nonkes LJ; van Bussel IP; Verheij MM; Homberg JR
    Behav Pharmacol; 2011 Dec; 22(8):723-38. PubMed ID: 22015806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin and psychostimulant addiction: focus on 5-HT1A-receptors.
    Müller CP; Carey RJ; Huston JP; De Souza Silva MA
    Prog Neurobiol; 2007 Feb; 81(3):133-78. PubMed ID: 17316955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of dopamine and serotonin activity blocks spontaneous and cocaine-activated behaviour.
    Carey RJ; Huston JP; Müller CP
    Prog Brain Res; 2008; 172():347-60. PubMed ID: 18772041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
    Giorgetti M; Tecott LH
    Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of serotonin in the actions of psychostimulants: molecular and pharmacological analyses.
    Cunningham KA; Bradberry CW; Chang AS; Reith ME
    Behav Brain Res; 1996; 73(1-2):93-102. PubMed ID: 8788484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray studies of psychostimulant-induced changes in gene expression.
    Yuferov V; Nielsen D; Butelman E; Kreek MJ
    Addict Biol; 2005 Mar; 10(1):101-18. PubMed ID: 15849024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
    Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
    Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double dissociating effects of sensory stimulation and cocaine on serotonin activity in the occipital and temporal cortices.
    Müller CP; De Souza Silva MA; Huston JP
    Neuropharmacology; 2007 Mar; 52(3):854-62. PubMed ID: 17116310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of cocaine-induced behavioral and neurochemical effects by serotonin1A receptor agonist/antagonist in mice.
    Nakamura S; Ago Y; Hayashi A; Itoh S; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Synapse; 2006 Dec; 60(7):479-84. PubMed ID: 16952156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine.
    Morris HV; Dawson GR; Reynolds DS; Atack JR; Rosahl TW; Stephens DN
    Pharmacol Biochem Behav; 2008 Jul; 90(1):9-18. PubMed ID: 18358520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence.
    Patkar AA; Mannelli P; Hill KP; Peindl K; Pae CU; Lee TH
    Hum Psychopharmacol; 2006 Aug; 21(6):367-75. PubMed ID: 16915581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine in the central nervous system.
    Chojnacka-Wójcik E
    Pol J Pharmacol; 1995; 47(3):219-35. PubMed ID: 8714755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by cocaine of G protein-activated inwardly rectifying K+ channels expressed in Xenopus oocytes.
    Kobayashi T; Nishizawa D; Iwamura T; Ikeda K
    Toxicol In Vitro; 2007 Jun; 21(4):656-64. PubMed ID: 17329078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
    Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
    Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder.
    Howell LL; Cunningham KA
    Pharmacol Rev; 2015; 67(1):176-97. PubMed ID: 25505168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on spontaneous and cocaine-induced behavior of pharmacological inhibition of noradrenergic and serotonergic systems.
    Carey RJ; DePalma G; Shanahan A; Damianopoulos EN; Müller CP; Huston JP
    Pharmacol Biochem Behav; 2008 Mar; 89(1):54-63. PubMed ID: 18155756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research.
    Ritz MC; Kuhar MJ
    Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.